$7.03 Billion is the total value of C WorldWide Group Holding A/S's 165 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 10.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| V | Buy | VISA INC | $955,858,000 | +14.6% | 9,082,646 | +2.2% | 13.59% | +7.3% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $516,222,000 | +8.1% | 538,230 | +2.4% | 7.34% | +1.2% |
| FB | Buy | FACEBOOK INCcl a | $491,966,000 | +15.9% | 2,879,184 | +2.4% | 6.99% | +8.5% |
| ECL | Buy | ECOLAB INC | $484,739,000 | -1.4% | 3,769,066 | +1.8% | 6.89% | -7.7% |
| C | Buy | CITIGROUP INC | $480,322,000 | +23.0% | 6,603,267 | +13.1% | 6.83% | +15.1% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $422,624,000 | +11.5% | 2,233,740 | +2.8% | 6.01% | +4.4% |
| GILD | Buy | GILEAD SCIENCES INC | $348,956,000 | +16.0% | 4,307,035 | +1.4% | 4.96% | +8.6% |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $336,458,000 | +6.5% | 3,220,921 | +2.0% | 4.78% | -0.3% |
| WFC | Buy | WELLS FARGO CO NEW | $329,827,000 | +2.0% | 5,980,528 | +2.5% | 4.69% | -4.5% |
| AMZN | Buy | AMAZON INC | $290,905,000 | +1.6% | 302,601 | +2.3% | 4.14% | -4.9% |
| PCLN | Buy | PRICELINE GRP INC | $196,645,000 | +0.8% | 107,408 | +3.0% | 2.80% | -5.7% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $152,260,000 | +31.8% | 881,596 | +7.6% | 2.16% | +23.4% |
| HDB | Buy | HDFC BANK LTD | $143,718,000 | +11.7% | 1,491,312 | +0.8% | 2.04% | +4.6% |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $80,486,000 | +8.0% | 2,143,435 | +0.5% | 1.14% | +1.1% |
| BIDU | Buy | BAIDU INCspon adr rep a | $67,443,000 | +50.5% | 272,286 | +8.7% | 0.96% | +41.0% |
| IBN | Buy | ICICI BK LTDadr | $43,669,000 | +1.3% | 5,101,590 | +6.2% | 0.62% | -5.0% |
| JNJ | Buy | JOHNSON & JOHNSON | $39,813,000 | +5.2% | 306,231 | +7.0% | 0.57% | -1.6% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $17,712,000 | +174.7% | 823,825 | +23.3% | 0.25% | +157.1% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $16,192,000 | +52.9% | 645,100 | +46.8% | 0.23% | +42.9% |
| INSM | Buy | INSMED INC | $13,964,000 | +475.1% | 447,429 | +216.3% | 0.20% | +435.1% |
| GKOS | Buy | GLAUKOS CORP | $9,617,000 | -10.1% | 291,425 | +13.0% | 0.14% | -15.4% |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $7,235,000 | +80.3% | 114,268 | +81.8% | 0.10% | +68.9% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $6,983,000 | – | 59,639 | +100.0% | 0.10% | – |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $6,635,000 | +22.3% | 122,801 | +27.1% | 0.09% | +14.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $5,742,000 | -30.9% | 326,269 | +30.4% | 0.08% | -34.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $5,800,000 | +650.3% | 38,146 | +535.8% | 0.08% | +583.3% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $5,555,000 | +35.6% | 122,469 | +0.8% | 0.08% | +27.4% |
| NUVA | New | NUVASIVE INC | $5,259,000 | – | 94,827 | +100.0% | 0.08% | – |
| ONCE | Buy | SPARK THERAPEUTICS INC | $4,667,000 | +49.4% | 52,349 | +0.1% | 0.07% | +40.4% |
| KTWO | Buy | K2M GROUP HLDGS INC | $4,267,000 | -4.6% | 201,192 | +9.6% | 0.06% | -10.3% |
| DERM | Buy | DERMIRA INC | $4,133,000 | +17.4% | 153,061 | +26.7% | 0.06% | +11.3% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $4,138,000 | -13.4% | 77,691 | +1.0% | 0.06% | -19.2% |
| CARA | Buy | CARA THERAPEUTICS INC | $3,988,000 | +57.0% | 291,341 | +76.6% | 0.06% | +46.2% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $3,821,000 | +41.2% | 242,156 | +11.1% | 0.05% | +31.7% |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $3,819,000 | -0.7% | 64,042 | +31.4% | 0.05% | -6.9% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $3,234,000 | +19.0% | 31,863 | +17.6% | 0.05% | +12.2% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $3,078,000 | +0.5% | 183,235 | +0.6% | 0.04% | -6.4% |
| ACHC | Buy | ACADIA HEALTHCARE PANY IN | $3,023,000 | +13.3% | 63,305 | +17.2% | 0.04% | +7.5% |
| OBLN | Buy | OBALON THERAPEUTICS INC | $2,632,000 | +9.3% | 276,211 | +13.7% | 0.04% | 0.0% |
| SNA | Buy | SNAP ON INC | $2,311,000 | +15.4% | 15,507 | +22.3% | 0.03% | +10.0% |
| AFAM | Buy | ALMOST FAMILY INC | $2,051,000 | +38.6% | 38,200 | +59.2% | 0.03% | +31.8% |
| OTEX | Buy | OPEN TEXT CORP | $1,961,000 | +63.0% | 48,700 | +65.6% | 0.03% | +55.6% |
| SBPH | Buy | SPRING BK PHARMACEUTICALS IN | $1,873,000 | +450.9% | 111,200 | +342.6% | 0.03% | +440.0% |
| STML | New | STEMLINE THERAPEUTICS INC | $1,776,000 | – | 160,000 | +100.0% | 0.02% | – |
| KMPH | Buy | KEMPHARM INC | $1,611,000 | +5.5% | 435,528 | +14.1% | 0.02% | 0.0% |
| HRTX | New | HERON THERAPEUTICS INC | $1,615,000 | – | 100,000 | +100.0% | 0.02% | – |
| PGR | New | PROGRESSIVE CORP OHIO | $1,375,000 | – | 28,400 | +100.0% | 0.02% | – |
| ANTM | New | ANTHEM INC | $950,000 | – | 5,000 | +100.0% | 0.01% | – |
| PFNX | Buy | PFENEX INC | $820,000 | -16.7% | 271,400 | +10.5% | 0.01% | -20.0% |
| VLRX | Buy | VALERITAS HLDGS INC | $800,000 | -50.1% | 246,978 | +5.6% | 0.01% | -54.2% |
| BAP | Buy | CREDICORP LTD | $455,000 | +118.8% | 2,216 | +90.9% | 0.01% | +100.0% |
| BLUE | Buy | BLUEBIRD BIO INC | $340,000 | +53.8% | 2,474 | +17.8% | 0.01% | +66.7% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $251,000 | +27.4% | 5,012 | +18.0% | 0.00% | +33.3% |
| RDUS | Buy | RADIUS HEALTH INC | $283,000 | +1.1% | 7,353 | +18.6% | 0.00% | 0.0% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $254,000 | +209.8% | 3,800 | +137.5% | 0.00% | +300.0% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $311,000 | +60.3% | 8,261 | +19.0% | 0.00% | +33.3% |
| XLRN | Buy | ACCELERON PHARMA INC | $201,000 | +45.7% | 5,376 | +18.4% | 0.00% | +50.0% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $203,000 | +43.0% | 18,515 | +18.1% | 0.00% | +50.0% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $198,000 | +11.2% | 16,146 | +49.6% | 0.00% | 0.0% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $156,000 | +0.6% | 13,300 | +19.8% | 0.00% | 0.0% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $82,000 | -44.2% | 1,417 | +16.5% | 0.00% | -50.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 37 | Q3 2023 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
| HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
| ICICI BK LTD | 37 | Q3 2023 | 2.1% |
| CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
| DEX INC | 37 | Q3 2023 | 0.5% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
| VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
| INSULET CORP | 37 | Q3 2023 | 0.3% |
| CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.